HIT Consultant March 29, 2021
Russ Kennedy, Chief Product Officer, Nasuni

Pharmaceutical companies today are distributed, global organizations, with research centers, manufacturing facilities, and regulatory management hubs spread all over the globe. To develop new treatments and bring them to market, all of these different functions need to collaborate more closely than ever. Using traditional, on-premises storage technologies, however, makes it difficult to share data quickly and securely, especially given that the research and manufacturing process can generate terabytes of unstructured data. 

Transferring data sets that large across a VPN, WAN, or via replication is simply not feasible. But there’s an even more fundamental problem: exponential file growth, especially at this level of volume, puts an enormous strain on storage hardware and network bandwidth. It’s never simple to predict storage needs,...

Today's Sponsors

Teladoc Health
Premier
TripleTree

Today's Sponsors

SalesSparx
Canton & Company

Today's Sponsor

HLTH

 
Topics: Analytics, Cloud, Pharma, Pharma / Biotech, Technology
NIH to test repurposing up to 7 drugs to treat COVID-19 symptoms at home
Decentralized Clinical Trials: Surviving & Thriving in the Clinical Research World of COVID-19
The FDA Seeks a New Way to Review Old Drugs Without Causing Prices to Soar
To Improve Competition In Generic Drug Markets, The FDA Should Discount User Fees For Small Players
Designing better antibody drugs with artificial intelligence